211 related articles for article (PubMed ID: 24798282)
1. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.
Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E
Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282
[TBL] [Abstract][Full Text] [Related]
2. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase.
Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905
[TBL] [Abstract][Full Text] [Related]
3. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
5. The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding.
Leo B; Schweimer K; Rösch P; Hartl MJ; Wöhrl BM
Retrovirology; 2012 Sep; 9():73. PubMed ID: 22962864
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase.
Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z
Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548
[TBL] [Abstract][Full Text] [Related]
7. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
9. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
10. Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.
Corona A; Di Leva FS; Thierry S; Pescatori L; Cuzzucoli Crucitti G; Subra F; Delelis O; Esposito F; Rigogliuso G; Costi R; Cosconati S; Novellino E; Di Santo R; Tramontano E
Antimicrob Agents Chemother; 2014 Oct; 58(10):6101-10. PubMed ID: 25092689
[TBL] [Abstract][Full Text] [Related]
11. Insights into the structure and activity of prototype foamy virus RNase H.
Leo B; Hartl MJ; Schweimer K; Mayr F; Wöhrl BM
Retrovirology; 2012 Feb; 9():14. PubMed ID: 22325739
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
[TBL] [Abstract][Full Text] [Related]
14. Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue.
Herman BD; Sluis-Cremer N
Biochem J; 2013 Oct; 455(2):179-84. PubMed ID: 23927736
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.
Chung S; Himmel DM; Jiang JK; Wojtak K; Bauman JD; Rausch JW; Wilson JA; Beutler JA; Thomas CJ; Arnold E; Le Grice SF
J Med Chem; 2011 Jul; 54(13):4462-73. PubMed ID: 21568335
[TBL] [Abstract][Full Text] [Related]
16. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.
Esposito F; Kharlamova T; Distinto S; Zinzula L; Cheng YC; Dutschman G; Floris G; Markt P; Corona A; Tramontano E
FEBS J; 2011 May; 278(9):1444-57. PubMed ID: 21348941
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
[TBL] [Abstract][Full Text] [Related]
18. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs.
Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E
J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
[TBL] [Abstract][Full Text] [Related]
20. 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
Tang J; Liu F; Nagy E; Miller L; Kirby KA; Wilson DJ; Wu B; Sarafianos SG; Parniak MA; Wang Z
J Med Chem; 2016 Mar; 59(6):2648-59. PubMed ID: 26927866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]